“…[3] While much development has been made with respect to arylation, [3a-j] acylation, [3k-l] amination, [3m-q] phosphonylation [3r-s] directly at the C3 position using easily available quinoxalin-2(1H)-ones, functionalization by benzyl, [4] alkyl [5] and fluoroalkyl [6] groups are less explored, despite the importance and predominance of this scaffold as pharmaceuticals that include MDR antagonist, aldose reductase inhibitor, MAO-A inhibitor, ion channel blocker, antitumor, anti-inflamatory, and anti-obesity agents ( Figure 1). [7][8][9] Very recently, C3 position of quinoxalin-2(1H)-one has been directly benzylated [4] and alkylated [10] using methylarenes and ethers, respectively (Scheme 1a). Three reports describing cyanoalkylation [11] at the C3 of quinoxalin-2(1H)-one have been very recently disclosed (Scheme 1b).…”